No abstract available
Publication types
-
Letter
-
Meta-Analysis
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aminoglycosides / administration & dosage
-
Aminoglycosides / adverse effects
-
Antibodies, Monoclonal, Humanized / administration & dosage
-
Antibodies, Monoclonal, Humanized / adverse effects
-
Antineoplastic Agents, Immunological / administration & dosage
-
Antineoplastic Agents, Immunological / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Clinical Trials, Phase III as Topic / statistics & numerical data*
-
Female
-
Follow-Up Studies
-
Gemtuzumab
-
Hepatic Veno-Occlusive Disease / chemically induced
-
Humans
-
Infant
-
Kaplan-Meier Estimate
-
Male
-
Multicenter Studies as Topic / statistics & numerical data*
-
Pilot Projects
-
Proportional Hazards Models
-
Randomized Controlled Trials as Topic / statistics & numerical data*
-
Remission Induction
-
Treatment Outcome
Substances
-
Aminoglycosides
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents, Immunological
-
Gemtuzumab